Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: Analysis of 5732 Japanese subjects

Gut

Volumn 49, Issue 3, 2001, Pages 335-340

  Yamaji, Y ^a,b,d   Mitsushima, T ^c,d   Ikuma, H ^c   Okamoto, M ^b,d   Yoshida, H ^b   Kawabe, T ^b   Shiratori, Y ^b   Saito, K ^c   Yokouchi, K ^d   Omata, M ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kameda General Hospital   (Japan)

^d Makuhari Clinic   (Japan)

Author keywords

Atrophic gastritis; Gastric cancer; Gastro oesophageal reflux disease; Helicobacter pylori; Oesophagitis

Indexed keywords

BACTERIUM ANTIBODY; PEPSINOGEN;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; JAPAN; MALE; NONHUMAN; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH CANCER;

ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; ENDOSCOPY, GASTROINTESTINAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGITIS, PEPTIC; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PEPSINOGEN A; STOMACH NEOPLASMS;

EID: 17944381898     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.49.3.335     Document Type: Article

References (57)

1. Long-term sequelae of Helicobacter pylori gastritis
2. NIH consensus conference. Helicobacter pylori in peptic ulcer disease
3. Infection with Helicobacter pylori
4. Helicobacter pylori gastritis and gastric MALT-lymphoma
5. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease
6. Helicobacter pylori in 205 consecutive endoscopy patients
7. Esophagitis and Helicobacter pylori in children: Incidence and therapeutic implications
8. Helicobacter pylori and gastro-oesophageal reflux disease - A prospective study
9. Reflux oesophagitis and Helicobacter pylori infection in elderly patients
10. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus
11. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis
12. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
13. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
14. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: An unexplored triangle
15. Clinical spectrum of gastroesophageal reflux disease after HP eradication in patients with duodenal ulcer
16. The appearance of GORD in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study
17. Prevalence of gastroesophageal reflux disease (GERD) in H. pyloripositive peptic ulcer disease and the impact of eradication therapy
18. Are gastroesophageal reflux disease (GERD) and peptic esophagitis (PE) a complication of the eradication of Helicobacter pylori (Hp) in patients with duodenal ulcer?
19. Not all Helicobacter pylori strains are created equal: Should all be eliminated?
20. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
21. Opposing time trends of peptic ulcer and reflux disease
22. Helicobacter pylori infection and adenocarcinoma of distal stomach
23. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
24. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
25. An international association between Helicobacter pylori infection and gastric cancer
26. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia
27. Serum pepsinogens as a screening test of extensive chronic gastritis
28. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma
29. Serum pepsinogens I and II and gastric acid output: Effect of gastritis
30. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels
31. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis
32. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates
33. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer
34. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan
35. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention
36. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine
37. Helicobacter pylori (Hp) and reflux esophagitis
38. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis
39. H pylori and gastric cancer
40. The prevalence of Helicobacter pylori infection in gastric cancer
41. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: A case-control study in Japan
42. Time-course of H. pylori antibody titres in patients with atrophic corpus gastritis
43. Identification of Helicobacter pylori in gastric specimens, gastric juice, saliva, and faeces of Japanese patients
44. Nested-polymerase chain reaction for the detection of Helicobacter pylori infection with novel primers designed by sequence analysis of urease A gene in clinically isolated bacterial strains
45. Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients
46. Helicobacter pylori and acid peptic disorders of the esophagus: Is it conceivable?
47. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
48. Cytotoxin production by Helicobacter pylori from patients with upper gastro-intestinal tract diseases
49. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: A prospective study
50. Helicobacter pylori infection and chronic gastric acid hyposecretion
51. High concentrations of ammonia, but not volatile amines, in gastric juice of subjects with Helicobacter pylori infection
52. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
53. Prevalence of Cag A-bearing Helicobacter pylori strains detected by the anti-Cag A assay in patients with peptic ulcer disease and in controls
54. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
55. High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan
56. High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan